Stephen Knight is a physician-investor with an MD/MBA from Yale who combines early research experience at AT&T Bell Labs and the NIH with deep biotech operating experience, giving him an unusual technical foundation for evaluating frontier biology companies. Beyond investing, he has co-founded multiple platform biotech companies like Beam Therapeutics and Prime Medicine, reflecting a hands-on company-creation approach where he works directly with academics to spin out science rather than only financing existing startups. Stephen Knight is a physician-investor with an MD/MBA from Yale who combines early research experience at AT&T Bell Labs and the NIH with deep biotech operating experience, giving him an unusual technical foundation for evaluating frontier biology companies. Beyond investing, he has co-founded multiple platform biotech companies like Beam Therapeutics and Prime Medicine, reflecting a hands-on company-creation approach where he works directly with academics to spin out science rather than only financing existing startups.